Trademark Search  /  ADPL

ADPL

● Live · Registered

U.S. federal trademark · Serial No. 97405280 · Reg. No. UK00003775551

Mark
ADPL
Status
Registered
Serial Number
97405280
Registration No.
UK00003775551
Filing Date
April 8, 2022
Registration Date
July 8, 2022
Class(es)
Class 005

Owners

Mercury Pharma Group Limited
03 · London, GB
Mercury Pharma Group Limited
03 · London, GB
Mercury Pharma Group Limited
03 · London, GB

Goods & Services

A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "ADPL" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.